Cytopenia: all 87 studies
Page 1 of 1. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Autoimmune Cytopenia Elimination by Chimeric Antigen Receptor T-cell TherapyNot yet recruitingNCT07790575Phase 1
- Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in AlsaceRecruitingNCT07312474
- Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T TherapyRecruitingNCT07212335Early Phase 1
- Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia PatientsRecruitingNCT07081087
- A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06948318Phase 3
- Early Intervention in High Risk CCUSRecruitingNCT06802146Early Phase 1
- BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune DiseasesRecruitingNCT06787989Phase 1
- Feasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor ConditionsRecruitingNCT06773871Not applicable
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
- Safety and Efficacy of Metformin for Treatment of Cytopenia in Children and Adolescents With Fanconi AnemiaRecruitingNCT06519786Phase 3
- Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of Therapies Directed to Repair the Bone Marrow MicroenvironmentRecruitingNCT06439173
- A Study of Emapalumab for Pediatric Aplastic AnemiaRecruitingNCT06430788Phase 2
- A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged CytopeniaRecruitingNCT06285825Phase 2
- OBS'CEREVANCE: French Cohort of Pediatric Autoimmune CytopeniaRecruitingNCT05937828
- Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune NeutropeniaRecruitingNCT05931718
- Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDSRecruitingNCT05350748
- Danazol for Treatment of Cytopenias in Patients With CirrhosisRecruitingNCT04873102Phase 2
- Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDSRecruitingNCT04741945Phase 2
- A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)RecruitingNCT04419649Phase 2
- CHIP/CCUS Natural History ProtocolRecruitingNCT04102423
- Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune CytopeniaRecruitingNCT04005638
- Pre-myeloid Cancer and Bone Marrow Failure Clinic StudyRecruitingNCT02958462Not applicable
- HSCT for Patients With Fanconi Anemia Using Risk-Adjusted ChemotherapyRecruitingNCT02143830Phase 2
- Screening for Hematology Branch ProtocolsEnrolling by invitationNCT00001620
- Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 DepletionActive, not recruitingNCT05236764Not applicableResults posted
- BMS-986253 in Myelodysplastic SyndromesTerminatedNCT05148234Phase 1/2Results posted
- Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyTerminatedNCT03733249Phase 1/2Results posted
- Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02566304Phase 2Results posted
- Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell TransplantTerminatedNCT02065869Phase 1/2Results posted
- Bortezomib to Treat Significant Complication of HSCTCompletedNCT01929980Phase 2Results posted
- Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesCompletedNCT01789255Phase 2Results posted
- Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic SyndromeCompletedNCT01165996Phase 1/2Results posted
- Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCTCompletedNCT01012492Phase 2Results posted
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic SyndromeTerminatedNCT00589316Phase 1Results posted
- MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaCompletedNCT00462605Phase 2Results posted
- Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative DisordersCompletedNCT00397813Phase 2Results posted
- Vorinostat in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00305773Phase 2Results posted
- Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)CompletedNCT00303472Phase 2Results posted
- Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory CytopeniasCompletedNCT00244010Not applicableResults posted
- Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic SyndromeTerminatedNCT00119366Phase 2Results posted
- 177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and CytopeniaWithdrawnNCT07025512Phase 2
- Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.Active, not recruitingNCT06276036Not applicable
- Cytopenias in Hospitalized Patients of Corona Virus Infection(COVID-19) During First and Other WavesCompletedNCT05258812
- TPO-Mimetic Use in Children for Hematopoietic FailureCompletedNCT04478227Early Phase 1
- Umbilical Cord Blood Treatment for Refractory Immune CytopeniaStatus unknownNCT04420494Not applicable
- National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.CompletedNCT04070612
- Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.CompletedNCT04057703
- Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune CytopeniaWithdrawnNCT03965624Phase 2
- Tacrolimus Treatment for Refractory Autoimmune CytopeniaStatus unknownNCT03918265Phase 4
- Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) HaploinsufficiencyWithdrawnNCT03733067Phase 1/2
- Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid MalignanciesActive, not recruitingNCT03682029Not applicable
- Autoimmune Cytopenia and BcR InhibitorsStatus unknownNCT03469895
- Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUSActive, not recruitingNCT03329365
- Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantActive, not recruitingNCT03301168Phase 1/2
- Improving Diagnosis in Idiopathic Cytopenia Using Gene SequencingStatus unknownNCT03026751
- Feasibility Study of Monitoring by Web-application on Cytopenia Related to ChemotherapyTerminatedNCT02866851Not applicable
- The National Myelodysplastic Syndromes (MDS) StudyCompletedNCT02775383
- Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In VitroCompletedNCT02104440Phase 2
- Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or DecitabineCompletedNCT01928537Phase 3
- Vitamin B6 on Relieving Linezolid-associated CytopeniasStatus unknownNCT01295801
- Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell TransplantNo longer availableNCT01200017
- Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic SyndromeCompletedNCT00988715Phase 1
- Studying Blood Samples in Young Patients With Cytopenia After a Donor Stem Cell TransplantStatus unknownNCT00898118
- Alemtuzumab and Rituximab in the Treatment of Refractory Autoimmune CytopeniasCompletedNCT00749112Phase 2/3
- Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)CompletedNCT00682799
- Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to TreatmentCompletedNCT00499070
- Low Bacterial Diet in Patients With CytopeniaCompletedNCT00367588Not applicable
- Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic SyndromesCompletedNCT00104962Phase 1
- A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)CompletedNCT00072969Phase 2
- Tipifarnib in Treating Patients With Myelodysplastic SyndromesCompletedNCT00005845Phase 1
- The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are AnemicCompletedNCT00002303Not applicable
- The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZTCompletedNCT00002302Not applicable
- A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related ComplexCompletedNCT00002281Not applicable
- A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to AzidothymidineCompletedNCT00002263Not applicable
- A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With CytopeniaCompletedNCT00002258Phase 1
- A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.CompletedNCT00002126Phase 2
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002073Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002072Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002071Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With AnemiaCompletedNCT00002042Not applicable
- Treatment Program for Anemia in AIDS PatientsCompletedNCT00002022Not applicable
- A Phase I/II Study of Recombinant Human GM-CSF in Patients With AIDS Virus Infection and LeukopeniaCompletedNCT00002009Phase 1
- An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and LeukopeniaCompletedNCT00002008Phase 1
- A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and LeukopeniaCompletedNCT00002007Not applicable
- A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and FeasibilityCompletedNCT00002006Phase 1
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic SyndromeCompletedNCT00001839Phase 2
- Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARCCompletedNCT00000711Phase 1